<?xml version="1.0" encoding="UTF-8"?>
<p>On the other hand, hyperimmune globulin and vaccine development may carry the risk of ADE, as discussed in detail by de Alwis and co‐workers (
 <xref rid="cytoa24047-bib-0050" ref-type="ref">50</xref>). Obviously, adaptative immune responses depend on the vaccine antigen load. NAbs of convalescent plasma from recovered COVID‐19 patients are supposedly different from those produced as consequence of vaccine presentation. NAbs are produced under proinflammatory conditions, which does not necessarily occur under vaccination conditions.
</p>
